Browsing Tag
Treg
2 posts
Nektar Therapeutics (NASDAQ: NKTR) rezpegaldesleukin shows dual action in skin and asthma — is this a pipeline turning point?
Nektar Therapeutics’ rezpegaldesleukin delivers dual efficacy in dermatitis and asthma in Phase 2b REZOLVE-AD trial. See how this Treg-based therapy is changing the game.
Genomma Lab expands portfolio with key brand acquisitions in US and Argentina
Genomma Lab Internacional S.A.B. de C.V. (BMV: LABB), a leading pharmaceutical and personal care product company based in…